Modern approaches to the treatment of urinary tract infection in children taking into account bacterial biofilm formation

O.O. Dobrik, M.O. Secunda, I.M. Derkach, O.M. Gorgota, R.E. Chalaniya, D.S. Dobrik

Abstract


Urinary tract infection (UTI) in children is a topical issue not only for nephrologists, but also for pediatricians. Success in the treatment depends on timely diagnosis of UTI and adequate antibiotic therapy. The work presents features of pathogens, such as the formation of beta-lactamases and the formation of bacterial biofilms, which at the present stage impede the diagnosis and lead to antibiotic resistance. Based on literature data and own observations, the use of Sulbactomax, a third-generation cephalosporin, in children with UTI has been substantiated.

Keywords


urinary tract infection; bacterial biofilms; Sulbactomax

References


Nakaz MOZ Ukraїni N 627 vіd 03.11. 2008 pro zatverdzhennja Protokolu lіkuvannja dіtej z іnfekcіjami sechovoї sistemi і tuboloіntersticіal'nim nefritom [Order of the Ministry of Health of Ukraine N 627 dd 03/11/2008 about approval of the Protocol of treatment of children with urinary infections and tubulo-interstitial nephritis]. (In Ukrainian). Available from: http://www.moz.gov.ua/ua/portal/dn_20081103_627.html/

M. Grabe et al. Guidelines on Urological Infections, 2015. Available from: https://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf

Ivanov DD. 2015 update in treatment of urinary infections in children. Zdorov’ja Ukrajini. 2016 Suppl Urology. Nephrology. Andrology;3(7):21-2. (In Ukrainian).

maidannyl VG. Pedіatrіja [Pediatrics]. Kharkiv: Folio; 2002. 1125 p.

Tekgül S, Dogan HS, Kocvara R, Nijman JM, Radmayr C, Stein R. Guidelines Associates: Silay MS, Undre S, Quaedackers J. Guideline on pediatric urology, 2012. Available from: http://uroweb.org/guideline/paediatric-urology/

Chernjavsky VI. Bacterial biofilms and infection (lecture). Annals of Mechnikov Institute. 2013;1:86-90. (In Ukrainian).

Vorobei ES, Voronkova OS, Vinnikov AI. Bacterial biofilms. Quorum sensing in bacteria in biofilms. Vіsnik Dnіpropetrovs'kogo unіversitetu. Bіologіja. Ekologіja. 2012:20(1):223-7. (In Russian).

Bezrodnyi BG, Petrenko OM. Biofilms of pathogenic bacteria and their role in chronicity of infectious process. Zdorov`ja Ukrajini. 2014;3:25-9 (In Ukrainian).

Sidashenko OI, Voronkova OS, Sirokvasha OA, Vinnikov AI. Biofilm as a specific form of bacteria organization and their role in infectious process. Vіsnik problem bіologіji і medicine. 2013; Issue 3 (2; 103):36-41 (In Russian).

Tets VV. Bakterial'nye soobshhestva [Bacterial associations]. In: Tets V, editor. Kletochnye soobshhestva [Cellular associations]. Saint-Petersburg: Izdatel'stvo SPbGMU; 1998. pp. 15-73. (In Russian).

Maltsev SV, Mansurova GS. What is biofilm? Prirodnaja medicina. 2013;1(13):86-9. (In Russian).

Marushko YuV, Hyshchak TV. Biofilm formation in respiratory diseases. influence of ambroxol on airway biofilms (literature review). Zdorov’ye Rebenka. 2016;2(70):88-94. doi: 10.22141/2224-0551.2.70.2016.73816. (In Ukranian).

Petukhova IN. Role of biofilms in chronicity of urinary tract. Urologija segodnja. 2013;2:14-5. (In Russian).

Lagun LV, Atanasova YuV, Tapalsky DV. Formation of microbial biofilms in causative agents of acute and chronic pyelonephritis. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2013;3:18-23. (In Russian).

Tets VV, Artemenko NK. Biofilms of agents induced urinary infections and use of fluroquinolone. Consilium Medicum. 2008;10(4). (In Ukrainian).

Choong S, Whitfield H. Biofilms and their role in infections in urology. BJU international. 2000;86(3):935-41. PMID: 11069430.

Kumon H. Management of biofilm infection in the urinary tract. World J Surg. 2000 Oct;24(10):1193-96. PMID: 11071460.

Solomon Wikero, et al. Molecular characterization of extended spectrum beta-lactamase producing Escherichia coli isolates in Brong-Ahafo regional hospital, Ghana. European Scientific Journal. 2017;13(9):365-77. doi: 10.19044/esj.2017.v13n9p365.

Tenke P, et al. Update on biofilm infections in the urinary tract. World Journal of Urology. 2012 Feb;30(1):51-7. PMID: 21590469. PMCID: PMC4629855. doi: 10.1007/s00345-011-0689-9.

NICE clinical guideline [CG54]. Urinary tract infection in under 16s: diagnosis and management. 2007. Available from: https://www.nice.org.uk/guidance/cg54 Accepted: August 207.

Fisher DJ, Steele RW, et al. Pediatric Urinary Tract Infection. Available from: http://emedicine.medscape.com/article/969643-overview Accepted: Aug 2016.

Joan L Robinson, Jane C Finlay, Mia Eileen Lang, Robert Bortolussi and Canadian Paediatric Society, Community Paediatrics Committee, Infectious Diseases and Immunization Committee. Urinary tract infection in infants and children: Diagnosis and management. Paediatr Child Health. 2014;19(6):315-9. PMCID: PMC4173959.

Alves MJ, Barreira JCM, Carvalho I, Trinta L, Perreira L, Ferreira ICFR, Pintado.M. Propensity for biofilm formation by clinical isolates from urinary tract infections: developing a multifactorial predictive model to improve antibiotherapy. Journal of Medical Microbiology. 2014 Mar;63(pt 3): 471-7. PMID: 24430252. doi: 10.1099/jmm.0.071746-0.

Glava 15.4 Osnovnye principy antibakterial'noj terapii [Chapter 15.4 Basic principles of antibiotic therapy]. Glava 15.4.3 Komponenta “mikroorganizm” [Chapter 15.4.3 Component microorganism]. Glava 15.4.3.2 Rezistentnost' k antibіotikam [Chapter 15.4.3.2. Antibiotic resistence]. In: Belousov YB, Moiseev VS, Lepakhin VK, editors. Klinicheskaja farmakologija i farmakoterapija [Clinical pharmacology and drug therapy]. Moscow; 1997. (In Russian).

Strachounski LS. Extended spectrum β-lactamases – rapidly spreading and underestimated problem. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2005;7(1):92-6. (In Russian).

Bogun LV. Beta-lactamses-induced resistance of microorganisms and the ways for its overcoming. Novosti meditsiny i farmatsii. 2007;19(227):20-1. (In Russian).

Khan AU, Musharraf A. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med Sci Monit. 2004;10(11):598-602. PMID: 15507850.

Absalon CP, Ymele-Leki, Watnick PI. The Bacterial biofilm matrix as a platform for protein delivery. MBio. 2012;3(4):e00127-12. doi: 10.1128 /mBio.00127-12.

Mostovoi YM. Cephalosporins: disappointments and optimism. Novosti meditsiny i farmatsii. 2011;19(391):12-4. (In Russian).

Yudina LV. Role of protected cephalosporins in treatment of lower respiratory tract. Ukraїns'kij medichnij chasopis. 2016;4(114):3-15. (In Russian).

Ivanov DD, Kushnirenko SV. Clinical experience in sulbactomax usage for pyelonephritis treatment in children. Novosti meditsiny i farmatsii. 2010;59311):11-2. (In Ukrainian).

Redko OK, Zagorodnii IM, Ponor OB. Antimicrobial resistance and benefits of protected cephalosporins III generation in treatment of children. Bolezni i antibiotiki. 2011;2(05):17-9. (In Ukrainian).

Prescribing information for Sulbactomax. Available from: http://compendium.com.ua/info/170655/sul_baktomaks




DOI: https://doi.org/10.22141/2224-0551.12.4.2017.107629

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru